Abstract:Background: Expression of cyclooxygenase (COX)-2 can be detected in the hepatocellular carcinoma (HCC). Aspirin, a non-steroidal anti-inflammatory drug, can inhibit the growth of HCC probably through the inhibition of COX-2 expression. Aims: To compare the effects of three kinds of selective COX-2 inhibitors (meloxicam, celecoxib and rofecoxib) on the growth of human liver cancer cell line SMMC-7721, and to observe the effect of rofecoxib, a highly selective COX-2 inhibitor, on the growth of HCC implanted in the liver of nude mice. Methods: The DNA synthesis of SMMC-7721 cells was determined by 3H-thymidine (3H-TdR) incorporation method. The expression of proliferating cell nuclear antigen (PCNA) was detected by immunocytochemistry. The terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay was used to detect cell apoptosis. Rofecoxib (30 mg/kg per day) was administered to HCC implanted nude mice for eight weeks, the volume and weight of the xenografts in situ were measured. Results: Meloxicam, celecoxib and rofecoxib could decrease the 3H-TdR incorporation significantly in a dose-dependent manner in SMMC-7721 cells. Their 50% inhibitory concentration (IC50) were 8.55×10-8 mol/L, 1.22×10-8 mol/L and 6.27×10-9 mol/L, respectively. After treated with the above three selective COX-2 inhibitors (1×10-5 mol/L) for 24 hours, the expression of PCNA in SMMC-7721 cells were decreased, and the apoptosis index was significantly increased compared with that of the controls (14.6%±2.8%, 21.6%±3.6% and 27.1%±3.5% vs. 1.0%±0.7%, P<0.01). The higher the selectivity of COX-2, the higher the apoptosis index (P<0.01). The xenografts in situ in nude mice treated with rofecoxib were significantly smaller than those of the controls, and the inhibition rates were 73.2% in volume and 78.1% in weight. Conclusions: All three kinds of selective COX-2 inhibitors can effectively inhibit the growth of SMMC-7721 cells in vitro in proportion to their selectivity. The inhibition of HCC growth in vivo by rofecoxib suggests it may be an effective drug in the treatment of HCC.

STUDY ON THE EXPRESSION OF CYCLOOXYGENASE-2 IN HEPATOCELLULAR CARCINOMA CELL LINES AND ON THE GROWTH INHIBITION EFFECT OF NS-398

NS-398, a Selective Cyclooxygenase 2 Inhibitor, Inhibited Cell Growth and Induced Cell Cycle Arrest in Human Hepatocellular Carcinoma Cell Lines.

Specific COX-2 Inhibitor NS398 Induces Apoptosis in Human Liver Cancer Cell Line HepG2 Through BCL-2

The Study of Selective Cyclooxygenase-2 Inhibitor NS-398 on Proliferation and Apoptosis of Human Colon Cancer Cells

Knockdown of Cyclooxygenase-2 Leads to Growth Inhibition and Cell Cycle Arrest in Hepatocellular Carcinoma Cells.

[Effects of Cyclooxygenase-2 Antisense Vector on Proliferation and Sensitivity to Cisplatin of H1299 Cells].

Cyclooxygenase-2-independent Mechanism Study of Selective Cyclooxygenase-2 Inhibitor on Proliferation and Apoptosis of Colon Caner Cells

Effects of NS398, an inhibitor of cyclooxygenase 2, on the growth and apoptosis of human squamous cell carcinoma cell line Tca8113

Inhibition Effect of NS-398 Via COX-2 Dependent and Independent Mechanisms in Human Pancreatic Cancer Cells

Growth-inhibitory Effects of Selective Cyclooxygenase-2 Inhibitor on Colon Cancer Cells and Its Possible Mechanisms

Overexpression of Cyclooxygenase-2 in Human HepG2, Bel-7402 and SMMC-7721 Hepatoma Cell Lines and Mechanism of Cyclooxygenase-2 Selective Inhibitor Celecoxib-Induced Cell Growth Inhibition and Apoptosis

Expression of the cyclooxygenase-2 gene and its clinical significance in non-small cell lung cancer

In Vitro Enhancement of Radiation-Induced Apoptosis in Human Hepatoma Cell Line HepG2 by a Selective Inhibitor of Cyclooxygenase-2 Enzyme NS -398

[Effects of Selective Cyclooxygenase-2 Inhibitor NS-398 on 5-Fluorouracil Chemotherapy and Progression of Colon Cells: an Experimental Study].

Cyclooxygenase-2 expression correlates with angiogenesis and vascular endothelial growth factor-A in non-small cell lung cancer

Mechanism and Effect of Selective Cyclooxygenase-2 Inhibitor NS-398 on Human Cervical Carcinoma Cells

Effects of Three Kinds of Selective Cyclooxygenase-2 Inhibitors on the Growth of Hepatocellular Carcinoma

Effect of NS-398 on Colon Cancer Cells

Effects of COX-2 Gene Expression Inhibited by Shrna on Growth of Hepatocellular Carcinoma HepG_2 Cells

Effect of Selective Cyclooxygenase-2 Inhibitor NS398 on the Proliferation and Apoptosis of Prostate Cancer Cell Line PC0-3 in Vitro

Combination of Octreotide with Specific Cyclooxygenase-2 Inhibitor Enhances the Inhibitory Effect on Growth of Human Hepatocellular Carcinoma